Product Update
-
Hospital
World’s First Generic Eribulin for Treatment of Metastatic Breast Cancer Launched in India
Emcure Pharmaceuticals, a leading integrated global pharmaceutical company from India, today, announced the launch of the world’s first generic version…
Read More » -
Product Update
U.S. FDA Approves Mylan and Biocon’s Fulphila™ (pegfilgrastim-jmdb)
Mylan N.V. and Biocon Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Mylan’s Fulphila™ (pegfilgrastim-jmbd),…
Read More » -
Corporate
Strides Shasun receives USFDA approval for Cinacalcet Hydrochloride Tablets
Strides Shasun Limited today announced that its wholly owned subsidiary Strides Pharma Global Pte. Limited has received final approval for…
Read More » -
News
Glenmark Pharmaceuticals and Helsinn Group Enter into an Exclusive Licensing Agreement for Launch of AKYNZEO® in India and Nepal
Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, and Helsinn Group (“Helsinn”), a Swiss pharmaceutical group focused on building…
Read More » -
News
Strides Shasun Receives USFDA Approval for Ibuprofen Softgel OTC Capsules
Strides Shasun Limited today announced that its wholly-owned subsidiary Strides Pharma Global Pte. Limited has received approval for Ibuprofen Capsules,…
Read More » -
News
Essilor Launches Revolutionary Varilux X Series Lenses in India
Essilor introduces a new vision frontier – arm’s length vision – with its new premium progressive lens Varilux X series.…
Read More » -
News
Biocon and Mylan Receive Approvals from the European Commission and TGA, Australia for Semglee™
Mylan N.V., one of the world’s leading pharmaceutical companies, and Biocon Ltd., Asia’s premier biopharmaceutical company, today announced that their…
Read More » -
Medical Device
Carestream’s Wireless Digital X-ray Technology On the Roster Again at NFL Combine
In addition to demonstrating their speed, agility, and strength at the 2018 National Football League Scouting Combine, top college football…
Read More » -
Diagnostics
Advanced Testing Option Available Now For Tuberculosis Patients
Tuberculosis continues to blight the future of India’s healthcare systems. India accounts for 420,000 deaths due to this disease while…
Read More » -
News
Cipla Launches Authorized Generic of Aloxi®
Cipla USA, Inc. (“Cipla”) announces the launch of an authorized generic version of Aloxi® in the United States under applicable…
Read More »
